AltStreet
EDGAR Verified
Primary Source · SEC.gov

CCA Longevity Fund V (US III), LLC

CIK 0002006757Fund Vehicle2024 vintage506(b), 3(c)

Raised

Pre-open

Investors

—

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

CCA Longevity Fund V (US III), LLC is a Delaware pooled investment fund focused on longevity and biotech investments, filed as an amended Form D on December 6, 2024. The filing indicates pre-open status with no capital raised or investor count disclosed, operating under exemptions 506(b) and 3(c). Director William Corry is listed as the related person, with no sales commissions stated.

This longevity/biotech pooled fund utilizes the standard 506(b) private placement exemption combined with 3(c) exclusion from Investment Company Act registration, typical for venture-style life sciences funds targeting accredited and qualified purchasers. The pre-open amended filing with undisclosed terms is consistent with institutional fund formation practices in the biotech sector.

Data Flags

generalAmendment filing in pre-open status; no capital raised or first sale date disclosed, suggesting administrative update prior to initial close
related_personsOnly one related person (William Corry as Director) listed; sparse governance disclosure for a pooled investment fund

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002006757
Entity NameCCA Longevity Fund V (US III), LLC
Exemption506(b), 3(c)
First Sale Date—
Filing DateDecember 6, 2024
Accession Number0002006757-24-000002
Total Amount Sold—
Total Investors—
Minimum Investment$0 (no stated minimum)
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

William Corry

Director · Vero Beach, FL

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.